ISRCTN17692710进行中（未招募）1 期
Phase 1 trial HMR code: 21-017. The full scientific title will be published within 30 months after the end of the trial
Alveron Pharma UK Ltd0 个研究点目标入组 24 人开始时间: 2023年1月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase 1 trial HMR code: 22-017Healthy volunteersISRCTN51803225eurocrine Biosciences (United States)134
已完成
1 期
Phase I trial, HMR code: 21-014The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN58651193Silence Therapeutics (United Kingdom)32
进行中（未招募）
1 期
Phase I trial HMR code: 23-007The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN10047421Gedeon Richter (Hungary)176
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-001Healthy volunteersISRCTN15245786Medherant Limited24